Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis.

Abstract

BACKGROUND Bodily pain and physical disability can negatively impact health-related quality of life (HRQL) in patients with osteoarthritis (OA). OBJECTIVE To assess the effects of treatment with a new agent, rofecoxib, on HRQL in patients with OA. STUDY DESIGN Randomized, double-blind, 6-week clinical trial comparing treatment with rofecoxib, 5 to 50 mg… (More)

Topics

Cite this paper

@article{Ehrich2001EffectOR, title={Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis.}, author={Elliot W Ehrich and James A. Bolognese and Douglas J. Watson and Sheldon Xiaodong Kong}, journal={The American journal of managed care}, year={2001}, volume={7 6}, pages={609-16} }